“Therapeutic Trial of Modified Levofloxacin (MOLVX) Against Induced Colorectal Aberrant Crypt Foci (Precancerous Tissue) in Mice”, Iraqi J. Vet. Med., vol. 46, no. 2, pp. 53–65, Dec. 2022, doi: 10.30539/ijvm.v46i2.1554.